Magnesium sulphate infusion suppresses the cardiac release of noradrenaline during a handgrip stress test

Canadian Journal of Cardiology

Volumn 18, Issue 2, 2002, Pages 133-140

  Ohtsuka, Sadanori ^a   Oyake, Yasuyuki ^a   Seo, Yoshihiro ^a   Eda, Kazuhiko ^a   Yamaguchi, Iwao ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Adrenaline; Catecholamines; Magnesium; Noradrenaline

Indexed keywords

ADRENALIN; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CATECHOLAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MAGNESIUM; MAGNESIUM SULFATE; MAGNESOL; NITRATE; NORADRENALIN; PLACEBO; SODIUM CHLORIDE;

ADRENALIN BLOOD LEVEL; ADULT; AGED; AORTA; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR SYSTEM; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY SINUS; DOSE RESPONSE; DRUG EFFECT; DRUG INFUSION; EFFERENT NERVE; EXERCISE TEST; FEMALE; HAND GRIP; HEART; HEART CATHETERIZATION; HEART DILATATION; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART RATE; HUMAN; ISCHEMIC HEART DISEASE; MALE; NORADRENALIN BLOOD LEVEL; NORADRENALIN RELEASE; PLASMA; POSTGANGLIONIC NERVE; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; SYMPATHETIC NERVE; VALVULAR HEART DISEASE;

AGED; ANALYSIS OF VARIANCE; CORONARY DISEASE; EPINEPHRINE; EXERCISE TEST; FEMALE; HAND STRENGTH; HEART CATHETERIZATION; HUMANS; INFUSIONS, INTRAVENOUS; MAGNESIUM SULFATE; MALE; MIDDLE AGED; MYOCARDIUM; NOREPINEPHRINE; PROBABILITY; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 0036110804     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Acute myocardial infarction, reperfusion injury, and intravenous magnesium therapy: Basic concepts and clinical implications
2. Magnesium and cardiovascular disease
3. Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at onset of reperfusion
4. Intravenous magnesium sulphate in suspected myocardial infarction: Results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)
5. Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: The second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)
6. Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality. Meta-analysis of magnesium in acute myocardial infarction
7. Effects of intravenous magnesium in suspected acute myocardial infarction: Overview of randomized trials
8. Cumulative meta-analysis of therapeutic trials for myocardial infarction
9. Voltage-sensitive Ca2+ channels in rat brain neocortical noradrenergic nerve terminals
10. Magnesium sulphate increases plasma noradrenaline and neuropeptide-Y-like immunoreactivity
11. Effect of magnesium sulphate infusion on circulating levels of noradrenaline and neuropeptide-Y-like immunoreactivity in patients with primary Raynaud's phenomenon
12. Plasma noradrenalin pharmacokinetics during mental challenge
13. Neurohumoral transmission: The autonomic and somatic motor nervous systems
14. Magnesium and cardiovascular disease
15. Regulation of noradrenalin release from cardiac sympathetic fibers in the dog by presynaptic alpha and beta receptors
16. Cardiac and pulmonary noradrenalin release and removal in the dog
17. Assessment of human sympathetic nervous system activity from measurements of noradrenalin turnover
18. Regulation of noradrenalin uptake by adenine nucleotides and divalent cations: Role for extracellular protein phosphorylation
19. Left ventricular function during isometric handgrip and cold stress in normal subjects
20. Abnormal cardiovascular reactivity in borderline and mild essential hypertension
21. Plasma noradrenalin and muscle sympathetic discharge during rhythmic exercise in humans
22. Hemodynamic effects of magnesium sulphate on the normal human heart
23. Effects of magnesium chloride on cardiovascular hemodynamics in the neurally intact dog
24. Effects of magnesium sulphate on the cardiovascular system, coronary circulation and myocardial metabolism in anaesthetized dogs
25. Conotoxin inhibits the acute activation of tyrosine hydroxylase and the stimulation of noradrenalin release by potassium depolarization of sympathetic nerve endings
26. Dominant role of N-type Ca2+ channels in evoked release of noradrenalin from sympathetic neurons
27. Intracellular electrolytes in cardiac failure
28. Prognostic importance of the serum magnesium concentration in patients with congestive heart failure
29. Cardiac sympathetic nervous activity in congestive heart failure: Evidence for increased neuronal norepinephrine release and preserved neuronal uptake